Review of therapeutic drug monitoring of infliximab in spondyloarthritis-Catching up with management concepts from other inflammatory conditions

Br J Clin Pharmacol. 2020 Feb;86(2):194-195. doi: 10.1111/bcp.14129. Epub 2020 Jan 14.

Authors

Nikola Mitrev¹, Viraj Kariyawasam^{1

2}

Affiliations

¹ Department of Gastroenterology, Blacktown Hospital, Blacktown, New South Wales, Australia.
² Department of Gastroenterology, Concord Repatriation General Hospital, Concord West, New South Wales, Australia.

No abstract available

Publication types

Comment

MeSH terms

Antirheumatic Agents*
Drug Monitoring
Humans
Infliximab
Spondylarthritis*

Substances

Antirheumatic Agents
Infliximab